Search Results - "Lucas, Jose J."
-
1
GSK3 and tau: two convergence points in Alzheimer's disease
Published in Journal of Alzheimer's disease (01-01-2013)“…Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that plays a key role in the pathogenesis of Alzheimer's disease (AD)…”
Get more information
Journal Article -
2
NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy
Published in The Journal of clinical investigation (01-07-2010)“…Use of lithium, the mainstay for treatment of bipolar disorder, is limited by its frequent neurological side effects and its risk for overdose-induced…”
Get full text
Journal Article -
3
Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3
Published in The Journal of neuroscience (10-05-2006)“…Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase that is particularly abundant in the CNS. Dysregulation of GSK-3…”
Get full text
Journal Article -
4
Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome
Published in Neurobiology of disease (01-07-2019)“…Autism spectrum disorders are early onset neurodevelopmental disorders characterized by deficits in social communication and restricted repetitive behaviors,…”
Get full text
Journal Article -
5
N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation
Published in The Journal of biological chemistry (03-08-2007)“…Although GSK-3 activity can be regulated by phosphorylation and through interaction with GSK-3-binding proteins, here we describe N-terminal proteolysis as a…”
Get full text
Journal Article -
6
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Published in Brain (London, England : 1878) (01-01-2011)“…Endocannabinoids act as neuromodulatory and neuroprotective cues by engaging type 1 cannabinoid receptors. These receptors are highly abundant in the basal…”
Get full text
Journal Article -
7
Neuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependent
Published in PloS one (05-08-2013)“…Glycogen synthase kinase-3 (GSK-3) inhibitors have been postulated as useful therapeutic tools for the treatment of chronic neurodegenerative and…”
Get full text
Journal Article -
8
GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration
Published in Frontiers in molecular neuroscience (01-01-2011)“…Increased GSK-3 activity is believed to contribute to the etiology of chronic disorders like Alzheimer's disease (AD), schizophrenia, diabetes, and some types…”
Get full text
Journal Article -
9
α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease
Published in Human molecular genetics (01-02-2012)“…Huntington's disease (HD) is the most common of nine inherited neurological disorders caused by expanded polyglutamine (polyQ) sequences which confer…”
Get full text
Journal Article -
10
Impaired ATF6α processing, decreased Rheb and neuronal cell cycle re-entry in Huntington's disease
Published in Neurobiology of disease (01-01-2011)“…Abstract The endoplasmic reticulum-stress response is induced in several neurodegenerative diseases and in cellular models of Huntington's disease. However,…”
Get full text
Journal Article -
11
Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418
Published in The Journal of biological chemistry (14-11-2003)“…Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer's disease. We…”
Get full text
Journal Article -
12
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease
Published in Acta neuropathologica communications (03-06-2022)“…Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene for which no therapies are available…”
Get full text
Journal Article -
13
Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration
Published in Neurobiology of aging (01-09-2006)“…Here we have tested whether tau modification either by point mutation or by hyperphosphorylation can exert maximal pathogenic effects or if, on the contrary,…”
Get full text
Journal Article -
14
Accumulation of Ubiquitin Conjugates in a Polyglutamine Disease Model Occurs without Global Ubiquitin/Proteasome System Impairment
Published in Proceedings of the National Academy of Sciences - PNAS (18-08-2009)“…Aggregation-prone proteins have been suggested to overwhelm and impair the ubiquitin/proteasome system (UPS) in polyglutamine (polyQ) disorders, such as…”
Get full text
Journal Article -
15
-
16
Tau phosphorylation in hippocampus results in toxic gain-of-function
Published in Biochemical Society transactions (01-08-2010)“…The MAP (microtubule-associated protein) tau binds to tubulin, the main component of MTs (microtubules), which results in the stabilization of MT polymers. Tau…”
Get more information
Journal Article -
17
Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome
Published in Brain pathology (Zurich, Switzerland) (01-09-2016)“…Ribosomes and protein synthesis have been reported to be altered in the cerebral cortex at advanced stages of Alzheimer's disease (AD). Modifications in the…”
Get full text
Journal Article -
18
Looking for novel functions of tau
Published in Biochemical Society transactions (01-08-2012)“…The lack or excess of the protein tau can be deleterious for neurons. The absence of tau can result in retarded neurogenesis and neuronal differentiation,…”
Get more information
Journal Article -
19
α-synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology
Published in Autophagy (01-03-2012)“…Huntington and Parkinson diseases (HD and PD) are two major neurodegenerative disorders pathologically characterized by the accumulation of the aggregate-prone…”
Get full text
Journal Article -
20
Proteasomal Expression, Induction of Immunoproteasome Subunits, and Local MHC Class I Presentation in Myofibrillar Myopathy and Inclusion Body Myositis
Published in Journal of neuropathology and experimental neurology (01-05-2004)“…Inclusion body myositis (IBM) and myofibrillar myopathy (MM) are diseases characterized by the abnormal accumulation of proteins in muscle fibers, including…”
Get full text
Journal Article